Cost-effectiveness of escitalopram versus citalopram in outpatients suffering from major depressive disorder

被引：0

|

作者：

Fantino, B.

Moore, N.

机构：

[1] ADIM, AGORAS, Lyon, France

[2] Victor Segalen Univ, Bordeaux, France

来源：

VALUE IN HEALTH | 2006年 / 9卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)63545-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：A313 / A313

页数：1

相关论文

共 50 条

[1] Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
Fantino, Bruno
Moore, Nicholas
Verdoux, Helene
Auray, Jean-Paul
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 107 - 115
[2] Escitalopram in major depressive disorder:: clinical benefits and cost effectiveness versus citalopram
Lancon, Christophe
Verpillat, Patrice
Annemans, Lieven
Despiegel, Nicolas
Francois, Clement
[J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (01) : 44 - 52
[3] Escitalopram and citalopram in the treatment of outpatients with major depressive disorder
Moore, N
Verdoux, H
Fantino, B
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S426 - S426
[4] Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
Mitchell, Matthew
[J]. AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (02): : 87 - 87
[5] Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
Mencacci, Claudio
Di Sciascio, Guido
Katz, Pablo
Ripellino, Claudio
[J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 87 - 99
[6] Escitalopram and citalopram in outpatients suffering from severe major depressive disorder: A prospective, observational, eight-week study
Lancon, C
Sapin, C
Note, I
Farisse, J
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S349 - S349
[7] A cost-effectiveness model of escitalopram, citalopram, and venlafaxine as first-line treatment for major depressive disorder in Belgium
Demyttenaere, K
Hemels, MEA
Hudry, J
Annemans, L
[J]. CLINICAL THERAPEUTICS, 2005, 27 (01) : 111 - 124
[8] Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey
Hemels, ME
Karamustafyoglu, O
Ozmen, E
Dilsad, S
Mene, S
[J]. VALUE IN HEALTH, 2005, 8 (03) : 392 - 392
[9] Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany
Kulp, W
Hemels, M
Greiner, W
Graf, VDJ
[J]. VALUE IN HEALTH, 2005, 8 (06) : A210 - A210
[10] A cost-effectiveness analysis of escitalopram and sertraline in the treatment of major depressive disorder
Armstrong, EP
Skrepnek, GH
Malone, DC
Erder, H
[J]. VALUE IN HEALTH, 2005, 8 (03) : 393 - 393

← 1 2 3 4 5 →